Evidence map›Paper›PMID 41839925›Full record

ArticleScientific reports2026

Synthesis, characterisation, computational study, amelioration of ruthenium kesar nanoparticle, antioxidant and glycolytic enzyme activity alterations in cirrhotic liver extract.

Rahul Kanaoujiya, Debabrata Dash, Raj Kumar Koiri, Ghulam Mustafa, Kamalakanta Behera, Shekhar Srivastava, Shruti Trivedi, Ambrish Kumar, Amit Jaiswal, Pratima Chauhan and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rahul Kanaoujiya *Department of Chemistry, Science Faculty, Central University of Allahabad, Prayagraj, Uttar Pradesh, 211002, India. rahul.k@allduniv.ac.in.
Debabrata Dash *Biochemistry Laboratory, Department of Zoology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, 470003, India.
Raj Kumar KoiriBiochemistry Laboratory, Department of Zoology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, 470003, India. rkkoiri@dhsgsu.edu.in.
Ghulam MustafaDepartment of Chemistry, Science Faculty, Central University of Allahabad, Prayagraj, Uttar Pradesh, 211002, India.
Kamalakanta BeheraDepartment of Chemistry, Science Faculty, Central University of Allahabad, Prayagraj, Uttar Pradesh, 211002, India.
Shekhar SrivastavaDepartment of Chemistry, Science Faculty, Central University of Allahabad, Prayagraj, Uttar Pradesh, 211002, India.
Shruti TrivediDepartment of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Ambrish KumarDepartment of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Amit JaiswalDepartment of Chemistry, C.M.P. Degree College, University of Allahabad, Prayagraj, 211002, India.
Pratima ChauhanAdvanced Nanomaterials Research Laboratory, Department of Physics, U. G. C. Centre of Advanced Studies, University of Allahabad, Prayagraj, 211002, India.
Ravindra Kumar RawatAdvanced Nanomaterials Research Laboratory, Department of Physics, U. G. C. Centre of Advanced Studies, University of Allahabad, Prayagraj, 211002, India.
Surya Prakash SinghAdvanced Nanomaterials Research Laboratory, Department of Physics, U. G. C. Centre of Advanced Studies, University of Allahabad, Prayagraj, 211002, India.
DikshaDepartment of Applied Sciences, Amritsar Group of Colleges, Amritsar, Punjab, 143109, India.
Divya BartariaDepartment of Chemistry, United College of Engineering & Research, Prayagraj, Uttar Pradesh, 211010, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cirrhosis represents a progressive vascular and metabolic disease, which results due to chronic inflammatory injury to the tissues and presents with aberrant tissue regeneration, fibrosis with nodular configurations, vascular remodeling, and enhanced portal pressures along with compromised liver functions. In close correlation with the abovementioned abnormalities are defects within the mechanisms of antioxidant defense and glycolytic metabolism. The study focuses on the determination of inherent structural characteristics of ruthenium dioxide nanoparticles and determines the modulatory effects of a ruthenium complex on the activities of antioxidant and glycolytic enzymes within the cirrhotic liver samples. Structural studies proved the successful creation of a rutile RuO

Indexed as

AntioxidantsGlycolysisLiverLiver CirrhosisMetal NanoparticlesRutheniumAnimalsMaleMolecular Docking SimulationNanoparticlesRatsSpectroscopy, Fourier Transform InfraredAntioxidantsRutheniumAntioxidant enzymeElectron localization functionGlycolytic enzymeLiver cirrhosisMolecular dockingMolecular electrostatic potential analysisNon-covalent interactionRuthenium-kesar nanoparticle

Identifiers

PMID41839925
PMCPMC13125602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.